Oxetorone: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 65: | Line 65: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{Antimigraine preparations}} | |||
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 18:42, 12 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information about Oxetorone, click here.
Synonyms / Brand Names: ®,
Overview
Ball-and-stick model | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C21H21NO2 |
Molar mass | 319.40 g/mol |
3D model (JSmol) | |
| |
(verify) |
Oxetorone is an antimigraine agent.[1]
Association with hyperprolactinemia has been described.[2] [3]
References
- ↑ Massiou H (2000). "[Prophylactic treatments of migraine]". Rev. Neurol. (Paris) (in French). 156 Suppl 4: 4S79–86. PMID 11139754.
- ↑ Pradalier A (December 1996). "Hyperprolactinaemia and depression induced by oxetorone". Cephalalgia. 16 (8): 560–1. doi:10.1046/j.1468-2982.1996.1608560.x. PMID 8980859.
- ↑ "Oxetorone - Wikipedia, the free encyclopedia".
Categories:
- Pages with script errors
- CS1 maint: Unrecognized language
- Pages with broken file links
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugs